Helex to present a Oral Presentation on its Lipid Nanoparticle-Mediated CRISPR-based Therapy for ADPKD in ASGCT 2025 taking place in New Orleans in May

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.